Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

CT scans can find serious prostate cancer even when PSA levels are low.

Using a laser to remove hair in the urethra after hypospadias repair is effective and minimally invasive.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.